Sheldon Whitehouse has spent the better part of a decade positioning himself as the Senate's moral weather vane: the guy who shouts about dark money, Supreme Court corruption, and the donor class's stranglehold on democracy. Bluesky loves him for it. His name shows up in liberal canon lists alongside Jamie Raskin and Elizabeth Warren, reliably invoked whenever someone needs a Democrat who actually sounds mad. The reputation is real enough. What's also real, sitting in the public disclosure filings at blindtrust.io, is a trading record that wins 11 times out of 36 scored trades, posts a mean 30-day alpha of negative 4.7 percent, and just moved six figures out of stocks in back-to-back May sessions. The floor speech and the brokerage account are telling two different stories.
The Social Picture
Right now, Whitehouse's name is circulating on Bluesky in two distinct registers. The first is the liberal-hero listicle: he's being name-dropped as part of the Democratic resistance caucus, the people you call when you need someone to sound genuinely angry about Leonard Leo's orbit and the Supreme Court's ethics swamp. The second register is more pointed: commentary about whether his grandstanding on judicial corruption actually moves anything. Ten posts in the last 24 hours. No Google News hits in the same window.
The man is beloved by exactly the people who can't pass a bill right now. It's the situation. But the gap between the reputation and the receipts is worth examining, because the receipts are public.
Three Sales in 90 Days
Per the Blind Trust disclosure record, Whitehouse filed three trades in the last 90 days, all sales.
On April 13, he sold JPMorgan Chase stock, amount disclosed in the $15,000-to-$50,000 range. On May 7, he sold Oracle, same range. On May 8, the day after the Oracle sale, he sold shares of Disability Access Corp (ticker: DA) in the $100,000-to-$250,000 range.
Two sales in two consecutive days, totaling as much as $300,000 on the high end of the disclosed ranges. Whether that's a routine rebalancing or something else is not a question the filing answers. The filing just shows the dates and the direction.
There are no flagged vote-trade overlaps in this window. None of the recent Senate votes Whitehouse cast line up with those three sales in a way that generates a timing flag. So the sales stand on their own as trades, not as a conflict-of-interest story. The story here is the broader record.
The Full Scorecard
Across 36 scored trades, Whitehouse is 11 for 36 positive, 25 negative, with a mean 30-day alpha of negative 4.7 percent against the S&P 500. That's the full sample.
The worst three trades in the record:
- A sale of KVUE on August 28, 2025, in the $1,000-to-$15,000 range, which produced a negative 23.0 percent 30-day alpha. No committee overlap.
- A sale of Nvidia on January 6, 2025, in the $15,000-to-$50,000 range, negative 22.3 percent alpha. That one does carry a Technology committee overlap.
- A sale of PepsiCo on March 30, 2026, in the $1,000-to-$15,000 range, negative 14.9 percent alpha. No committee overlap.
Selling Nvidia in January 2025, right before a historic AI-driven run, while sitting on a committee with Technology jurisdiction, and losing 22.3 points to the market in 30 days. The interpretation is yours.
Where the Committee Overlap Lives
Whitehouse sits on the Senate Committee on Finance (with subcommittees covering Health Care, Taxation and IRS Oversight, and International Trade), the Senate Committee on the Judiciary, the Senate Committee on Environment and Public Works, and the Senate Committee on the Budget. That's a wide jurisdiction net.
The Blind Trust committee-overlap trade log flags five trades where the ticker falls inside his committee jurisdictions:
- UnitedHealth Group sold September 4, 2025, $15K-$50K, plus 6.5 percent alpha, Healthcare overlap.
- Mastercard sold February 23, 2026, $1K-$15K, plus 4.4 percent alpha, Financial Services overlap.
- Nvidia sold July 7, 2025, $15K-$50K, plus 3.0 percent alpha, Technology overlap.
- Nvidia sold October 20, 2025, $15K-$50K, plus 2.8 percent alpha, Technology overlap.
- UnitedHealth Group sold August 28, 2025, $15K-$50K, plus 2.6 percent alpha, Healthcare overlap.
All five of those committee-overlap trades are positive alpha. The five trades where his committee jurisdiction and his trade direction aligned all beat the market in the 30 days following the sale. The full sample is 11 of 36 positive. The committee-overlap subset is five for five positive.
That's a sample of five. It could mean everything. It could mean nothing. The receipts are public. Make of them what you make of them.
The Man Who Votes About Finance, Sits on Finance, and Sells Healthcare Stocks
Whitehouse is not some backbench appropriator. He's on the Finance Committee, which handles healthcare legislation, tax law, and trade policy. He's on Judiciary, which is where the Supreme Court ethics fights he's famous for actually live procedurally. When he sells UnitedHealth Group in September 2025 and it outperforms the market by 6.5 points in the next month, that's a trade that sits in the intersection of his professional responsibilities and his personal portfolio.
The Senate's rules require disclosure. They don't require divestiture, recusal, abstention, or any visible sign of discomfort. Members are invited to vote on legislation affecting sectors they hold, sell into rallies they may or may not have seen coming, and file the paperwork 30 to 45 days later. That's the system as designed.
The Votes This Quarter
The recent vote record shows Whitehouse engaged on two sets of issues: housing and Iran war powers. He voted Yea on the motion to proceed for the 21st Century ROAD to Housing Act on June 16, and again on cloture on June 18, then did not vote on the final June 22 passage. He backed both Iran war powers resolutions, the Senate version on June 24 (which failed) and the House concurrent resolution on June 23 (which passed).
None of those votes trigger a committee-overlap flag under his assignments. Housing at the floor level is not his committee's remit in a way that generates a conflict angle on the disclosed trades. The Iran war powers votes are clean floor votes, no portfolio connection in the filings.
The three trades filed this quarter, JPMorgan, Oracle, and the DA sale, don't line up timing-wise with any of the recent votes in a way the overlap algorithm flagged. So the trade and vote calendars are not the story here. The story is the longer pattern.
What the Portfolio Says About the Senator
A senator who campaigns on accountability and dark-money exposure, who has made his name demanding that people with power disclose what they own and recuse themselves from decisions they have an interest in, holds a portfolio that has lost to the market 25 times out of 36 scored trades and posts a mean alpha of negative 4.7 percent.
The five trades that beat the market meaningfully all sit inside his committee jurisdictions.
The three trades filed in the last 90 days are all sales, including a six-figure exit from DA in May. The timing on the two consecutive May sales is what it is: disclosed, dated, and sitting in the public record.
Whitehouse is one of the cleaner hands in a chamber full of much louder financial conflicts. The alpha record is largely a losing one. But the committee-overlap subset is not, and the system that permits that intersection is exactly the system he's built his career complaining about when other people benefit from it.
The full disclosure record is at Blind Trust. The votes are in the Congressional Record. The math is the math: 11 of 36, negative 4.7 on average, five for five when the trade touches his committee's turf.
Take that for what it's worth.